Aditya Birla Sun Life Pharma and Healthcare Fund · Direct · Growth
NAV
₹37.1600
as of 17 Jun 2026
Expense Ratio
—
see scheme documents
Lumpsum returns (CAGR)
- 1Y
- +13.02%
- 3Y
- +23.77%
- 5Y
- +14.42%
- Since Inception
- +20.83%
SIP returns (XIRR)
- 1Y
- +17.06%
- 3Y
- +15.74%
- 5Y
- +17.45%
- Since Inception
- +18.63%
Performance Comparison
Thinking about Aditya Birla Sun Life Pharma and Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
- 1Sun Pharmaceutical Industries Limited13.17%
- 2Apollo Hospitals Enterprise Limited7.20%
- 3Torrent Pharmaceuticals Limited4.76%
- 4J.B. Chemicals & Pharmaceuticals Limited4.71%
- 5Aurobindo Pharma Limited4.49%
- 6Ajanta Pharmaceuticals Limited4.05%
- 7Lupin Limited4.00%
- 8Mankind Pharma Ltd3.88%
- 9Fortis Healthcare Limited3.87%
- 10Abbott India Limited3.65%
Investment Objective
Aditya Birla Sun Life Pharma and Healthcare Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Aditya Birla Sun Life Pharma and Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by Aditya Birla Sun Life Mutual Fund. The fund has been operational for over 6 years.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations